Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786447 · ClinicalTrials.gov registry record
Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI
A clinical trial, sponsored by Banyan Biomarkers.
- Terminated
- Registry status
- 111
- Enrollment target
NCT01786447 is a clinical trial that was terminated before completion, run by Banyan Biomarkers. The registered enrollment target is 111 participants.
The verdict
NCT01786447 was terminated before completion, sponsored by Banyan Biomarkers.
- TERMINATED
- Registry status
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if specific brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI as well as in orthopedic control subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01786447
The ClinicalTrials.gov registry entry for NCT01786447 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Banyan Biomarkers, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01786447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01786447 about?
NCT01786447 is a clinical study titled "Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI". The purpose of this study is to determine if specific brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injur...
What is the current status of trial NCT01786447?
This trial is currently terminated. The enrollment target is 111 participants. The study started on 2010-04. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT01786447?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.